Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.08 USD | -4.83% | -12.55% | -2.77% |
05-09 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
05-08 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
501M | - | |||||
121B | ||||||
107B | ||||||
24.82B | - | |||||
22.48B | - | |||||
18.32B |